News in Brief
Health - Jan 11
Roche launches two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer
Roche launches two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer
Pharmacology - Jan 11
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene
History - Jan 10
THURS 28 JAN.: MAKING ART MODERN? VIEWS FROM THE ITALIAN RENAISSANCE- Talk by Robert Brennan with a response by Wolf-Dietrich Löhr
THURS 28 JAN.: MAKING ART MODERN? VIEWS FROM THE ITALIAN RENAISSANCE- Talk by Robert Brennan with a response by Wolf-Dietrich Löhr
Environment - Jan 7
More Root Carbon in Extensive Cultivation Systems - the Greenhouse Gas Inventory Is Optimised
More Root Carbon in Extensive Cultivation Systems - the Greenhouse Gas Inventory Is Optimised
Economics - Jan 7
Keep it simple: Exploring the precarious world of economic forecasting with Prof Michael Gasiorek
Keep it simple: Exploring the precarious world of economic forecasting with Prof Michael Gasiorek
science wire
« BACK
Health - Pharmacology - 29.10.2020
Pharmacology - 29.10.2020
Pharmacology - 29.10.2020 
Drug consumption highs and lows in latest wastewater report
Queensland has the highest regional MDMA consumption in Australia and the second highest of cocaine and methyl amphetamine, according to a report released by the Australian Criminal Intelligence Commission today.
Health - Pharmacology - 28.10.2020
Health - Pharmacology - 28.10.2020
Pharmacology - Economics / Business - 27.10.2020
Pharmacology - Health - 26.10.2020
Health - Pharmacology - 26.10.2020 
Localized vaccination surveillance could help prevent measles outbreaks
Access to more localized data on childhood vaccination coverage, such as at the school or neighborhood levels, could help better predict and prevent measles outbreaks in the United States, according to a new University of Michigan study.
Health - Pharmacology - 26.10.2020
Health - Pharmacology - 26.10.2020
Pharmacology - Health - 26.10.2020
Pharmacology - Health - 26.10.2020
Pharmacology - Health - 23.10.2020
Pharmacology - 22.10.2020
Pharmacology - Health - 21.10.2020
Health - Pharmacology - 21.10.2020
Health - Pharmacology - 20.10.2020
Pharmacology - Health - 20.10.2020
Health - Pharmacology - 19.10.2020
Health - Pharmacology - 18.10.2020
Health - Pharmacology - 16.10.2020
Health - Pharmacology - 16.10.2020
Pharmacology - Health - 16.10.2020
Health - Pharmacology - 15.10.2020
Health - Pharmacology - 15.10.2020
Pharmacology - Health - 14.10.2020
Health - Pharmacology - 13.10.2020
Health - Pharmacology - 13.10.2020
Health - Pharmacology - 12.10.2020
Pharmacology - Health - 12.10.2020 
More young adults are abstaining from alcohol
Fewer college-age Americans drink alcohol, compared to nearly 20 years ago, according to a new study.
Health - Pharmacology - 09.10.2020
Health - Pharmacology - 09.10.2020
Health - Pharmacology - 08.10.2020 
Role-playing computer game helps players understand how vaccines work on a global scale
A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.
Health - Pharmacology - 08.10.2020
Health - Pharmacology - 06.10.2020
Pharmacology - 06.10.2020
Pharmacology - Health - 05.10.2020
Health - Pharmacology - 01.10.2020
Pharmacology - Health - 01.10.2020
Health - Pharmacology - 30.09.2020
Health - Pharmacology - 30.09.2020
Health - Pharmacology - 29.09.2020
Pharmacology - Health - 29.09.2020
Health - Pharmacology - 27.09.2020
Pharmacology - Health - 24.09.2020
Health - Pharmacology - 24.09.2020 
University of Sydney to advance COVID-19 DNA vaccine to human trials
The University of Sydney is announcing the commencement of an extended Phase 1 Human Trial in Australia, evaluating a COVID-19 gene-based vaccine developed by BioNet and Technovalia and delivered via a needle-free system.
Pharmacology - Health - 23.09.2020
Life Sciences - Pharmacology - 21.09.2020 
Discovery of a druggable pocket in the SARS-CoV-2 Spike protein could stop virus in its tracks
Professor Imre Berger University of Bristol Professor Christiane Schaffitzel University of Bristol 3D structure image of SARS CoV-2 Spike protein University of Bristol 21 September 2020 A druggable pocket in the SARS-CoV-2 Spike protein that could be used to stop the virus from infecting human cells has been discovered by an international team of scientists led by the University of Bristol.
Health - Pharmacology - 21.09.2020
Pharmacology
Results 101 - 150 of 2145.
Novartis acquires Vedere Bio, adding novel optogenetic gene therapy technology for treating blindness
Acquisition expands the Novartis footprint in ophthalmology and enhances the company's position as an AAV-based gene therapy powerhouse.
Acquisition expands the Novartis footprint in ophthalmology and enhances the company's position as an AAV-based gene therapy powerhouse.
Highs and lows in drug consumption in latest wastewater monitoring report
Queensland has the highest regional MDMA consumption in Australia and the second highest of cocaine and methyl amphetamine, according to a report released by the Australian Criminal Intelligence Commission today.
Queensland has the highest regional MDMA consumption in Australia and the second highest of cocaine and methyl amphetamine, according to a report released by the Australian Criminal Intelligence Commission today.
Queensland has the highest regional MDMA consumption in Australia and the second highest of cocaine and methyl amphetamine, according to a report released by the Australian Criminal Intelligence Commission today.
U.S. News & World Report: UC San Diego #1 for Gastroenterology and Hepatology Research
Retired Navy Lieutenant, who is now in cancer remission and on liver transplant list, is an example of how translational research leads to life-saving approaches and treatments U.S. New
Retired Navy Lieutenant, who is now in cancer remission and on liver transplant list, is an example of how translational research leads to life-saving approaches and treatments U.S. New
Cancer anti-sickness drug offers hope for hallucinations in Parkinson’s
A world-first double-blind clinical trial led by UCL researchers will investigate if a powerful drug used to treat nausea in chemotherapy patients could alleviate hallucinations in people with Parkinson's.
A world-first double-blind clinical trial led by UCL researchers will investigate if a powerful drug used to treat nausea in chemotherapy patients could alleviate hallucinations in people with Parkinson's.
Access to more localized data on childhood vaccination coverage, such as at the school or neighborhood levels, could help better predict and prevent measles outbreaks in the United States, according to a new University of Michigan study.
COVID-19 vaccines: McGill researchers track the global race
McGill University professor Nicole Basta and her team have created an interactive online COVID-19 vaccine tracker , that provides real-time updates on progress in developing a safe and effective vaccine.
McGill University professor Nicole Basta and her team have created an interactive online COVID-19 vaccine tracker , that provides real-time updates on progress in developing a safe and effective vaccine.
What’s the STORY of infectious diseases in the UK?
A study looking at how children's immune systems respond to COVID-19, and to vaccines for other infectious diseases, is asking children under the age of 20 who live in the Bristol area to consider taking part. The research project is being run by the Bristol Children's Vaccine Centre (BCVC) at Bristol Medical School, and the Oxford Vaccine Group which is part of the University of Oxford.
A study looking at how children's immune systems respond to COVID-19, and to vaccines for other infectious diseases, is asking children under the age of 20 who live in the Bristol area to consider taking part. The research project is being run by the Bristol Children's Vaccine Centre (BCVC) at Bristol Medical School, and the Oxford Vaccine Group which is part of the University of Oxford.
Trial will test existing drugs against rare blood cancer
A clinical trial designed to test existing drugs in the treatment of a rare blood cancer has been launched at the Universities of Birmingham and Warwick.
A clinical trial designed to test existing drugs in the treatment of a rare blood cancer has been launched at the Universities of Birmingham and Warwick.
UCLA physician-scientist elected to National Academy of Medicine
"His track record of quickly turning breakthroughs in the laboratory into new therapies is impeccable," Jonsson Cancer Center director Dr. Michael Teitell said of Ribas.
"His track record of quickly turning breakthroughs in the laboratory into new therapies is impeccable," Jonsson Cancer Center director Dr. Michael Teitell said of Ribas.
How to stay safe from flu during the COVID-19 pandemic
Influenza is a serious illness that can make you miserable. At its worst, it can be fatal. As North America enters its first full flu season since the start of the COVID-19 pandemic, many are wondering about the intersection of these two respiratory viruses.
Influenza is a serious illness that can make you miserable. At its worst, it can be fatal. As North America enters its first full flu season since the start of the COVID-19 pandemic, many are wondering about the intersection of these two respiratory viruses.
Q&A: When Will a COVID-19 Vaccine Be Ready?
UC San Diego's fall plan continues to evolve, informed by the university's Return to Learn program.
UC San Diego's fall plan continues to evolve, informed by the university's Return to Learn program.
UCL academics named as Future Leaders Fellows
Seven UCL academics have been awarded UKRI Future Leaders fellowships, and will receive government investment to support their research.
Seven UCL academics have been awarded UKRI Future Leaders fellowships, and will receive government investment to support their research.
Roche to launch laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients
The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of SARS-CoV-2 infection This new solution will run on all Roche cobas e immunochemistry analys
The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of SARS-CoV-2 infection This new solution will run on all Roche cobas e immunochemistry analys
Funding allows researchers to uncover the secrets of COVID-19 immunity
Federal funding will help a team of researchers determine how long immunity lasts in people who've recovered from COVID-19, critical information as the world waits for a vaccine.
Federal funding will help a team of researchers determine how long immunity lasts in people who've recovered from COVID-19, critical information as the world waits for a vaccine.
Fewer college-age Americans drink alcohol, compared to nearly 20 years ago, according to a new study.
A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.
Trump’s COVID-19 treatments suggest severe illness, Berkeley expert says
President Donald Trump boards Marine One on Monday to return to the White House after receiving treatments for covid-19 at Walter Reed National Military Medical Center.
President Donald Trump boards Marine One on Monday to return to the White House after receiving treatments for covid-19 at Walter Reed National Military Medical Center.
New Phase III analysis demonstrates Novartis Beovu showed improvement in best-corrected visual acuity in wet AMD patients with early persistent fluid
In a post-hoc analysis of HAWK and HARRIER , fewer Beovu (brolucizumab ) patients had early persistent fluid (12 .5% vs.
In a post-hoc analysis of HAWK and HARRIER , fewer Beovu (brolucizumab ) patients had early persistent fluid (12 .5% vs.
Opinion: Coronavirus - the three types of vaccine hesitancy authorities need to combat
Honorary Research Associate Annamaria Carusi (UCL Science & Technology Studies) examines the three types of vaccine hesitancy facing authorities' efforts to build public trust in a coronavirus vaccine, including fears over civil liberties, animal welfare and testing.
Honorary Research Associate Annamaria Carusi (UCL Science & Technology Studies) examines the three types of vaccine hesitancy facing authorities' efforts to build public trust in a coronavirus vaccine, including fears over civil liberties, animal welfare and testing.
Zolgensma data including patients with more severe SMA at baseline further demonstrate therapeutic benefit, including prolonged event-free survival, increased motor function and milestone achievement
Nearly two-thirds of patients (65.6%) in STR1VE-EU have already achieved developmental motor milestones not observed in the natural history of SMA Type 1 at a mean duration of follow-up of 10&
Nearly two-thirds of patients (65.6%) in STR1VE-EU have already achieved developmental motor milestones not observed in the natural history of SMA Type 1 at a mean duration of follow-up of 10&
New trial to treat Covid-19 in care homes using anti-TNF drug begins
Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.
Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.
Opinion: Coronavirus - how the pharma industry is changing to produce a vaccine on time
Research Fellow Beatrice Melinek and Dr Stephen Morris (both UCL Biochemical Engineering) write how medical developments accelerate during crises, and share hopes for the production of a successful vaccine for Covid-19. To bring COVID-19 under control a vaccine needs to be available to every nation, rich and poor - and it needs to happen quickly.
Research Fellow Beatrice Melinek and Dr Stephen Morris (both UCL Biochemical Engineering) write how medical developments accelerate during crises, and share hopes for the production of a successful vaccine for Covid-19. To bring COVID-19 under control a vaccine needs to be available to every nation, rich and poor - and it needs to happen quickly.
Analysis: A million deaths from coronavirus - seven experts consider key questions
Professor Susan Michie (UCL Psychology & Languages Sciences) and Professor Robert West (UCL Epidemiology & Health) join experts in answering questions about the coronavirus, future pandemics and call for "a long-term vision and commitment to have short-term future success.
Professor Susan Michie (UCL Psychology & Languages Sciences) and Professor Robert West (UCL Epidemiology & Health) join experts in answering questions about the coronavirus, future pandemics and call for "a long-term vision and commitment to have short-term future success.
The University of Sydney is announcing the commencement of an extended Phase 1 Human Trial in Australia, evaluating a COVID-19 gene-based vaccine developed by BioNet and Technovalia and delivered via a needle-free system.
Novartis Provides Update on AVXS-101 Intrathecal Clinical Development Program
Novartis Gene Therapies to initiate new pivotal confirmatory study to evaluate use of AVXS-101 intrathecal (I T) formulation in older patients with SMA to further support registration Basel, Septembe
Novartis Gene Therapies to initiate new pivotal confirmatory study to evaluate use of AVXS-101 intrathecal (I T) formulation in older patients with SMA to further support registration Basel, Septembe
Professor Imre Berger University of Bristol Professor Christiane Schaffitzel University of Bristol 3D structure image of SARS CoV-2 Spike protein University of Bristol 21 September 2020 A druggable pocket in the SARS-CoV-2 Spike protein that could be used to stop the virus from infecting human cells has been discovered by an international team of scientists led by the University of Bristol.
Novartis Kisqali receives the highest rating of any CDK4/6 inhibitor on the ESMO Magnitude of Clinical Benefit Scale
Kisqali is the only CDK4/6 inhibitor, in combination with endocrine therapy, to achieve a perfect 5 out of 5 score - confirming substantial benefit for premenopausal women with HR+/HER2- advanced bre
Kisqali is the only CDK4/6 inhibitor, in combination with endocrine therapy, to achieve a perfect 5 out of 5 score - confirming substantial benefit for premenopausal women with HR+/HER2- advanced bre
News in Brief
Health - Jan 11
Roche launches two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer
Roche launches two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer
Pharmacology - Jan 11
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene
History - Jan 10
THURS 28 JAN.: MAKING ART MODERN? VIEWS FROM THE ITALIAN RENAISSANCE- Talk by Robert Brennan with a response by Wolf-Dietrich Löhr
THURS 28 JAN.: MAKING ART MODERN? VIEWS FROM THE ITALIAN RENAISSANCE- Talk by Robert Brennan with a response by Wolf-Dietrich Löhr
Environment - Jan 7
More Root Carbon in Extensive Cultivation Systems - the Greenhouse Gas Inventory Is Optimised
More Root Carbon in Extensive Cultivation Systems - the Greenhouse Gas Inventory Is Optimised
Economics - Jan 7
Keep it simple: Exploring the precarious world of economic forecasting with Prof Michael Gasiorek
Keep it simple: Exploring the precarious world of economic forecasting with Prof Michael Gasiorek